Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.

Maleck V Vasseur Michel Laurentie 1 Jean-Guy Rolland 1 Agnès Perrin-Guyomard 1 Jérôme Henri 1 Aude A Ferran 2 Pierre-Louis Toutain 2 Alain Bousquet-Mélou 2, *
* Auteur correspondant
1 Anses Laboratoire de Fougères
2 Physiologie et Toxicologie Expérimentales
Abstract : The combination of efficacious treatment against bacterial infections and mitigation of antibiotic resistance amplification in gut microbiota is a major challenge for antimicrobial therapy in food-producing animals. In rats, we evaluated the impact of cefquinome, a fourth-generation cephalosporin, on both Klebsiella pneumoniae lung infection and intestinal flora harboring CTX-M-producing Enterobacteriaceae. Germfree rats received a fecal flora specimen from specific-pathogen-free pigs, to which a CTX-M-producing Escherichia coli strain had been added. K. pneumoniae cells were inoculated in the lungs of these gnotobiotic rats by using either a low (10(5) CFU) or a high (10(9) CFU) inoculum. Without treatment, all animals infected with the low or high K. pneumoniae inoculum developed pneumonia and died before 120 h postchallenge. In the treated groups, the low-inoculum rats received a 4-day treatment of 5 mg/kg of body weight cefquinome beginning at 24 h postchallenge (prepatent phase of the disease), and the high-inoculum rats received a 4-day treatment of 50 mg/kg cefquinome beginning when the animals expressed clinical signs of infection (patent phase of the disease). The dose of 50 mg/kg targeting the high K. pneumoniae inoculum cured all the treated rats and resulted in a massive amplification of CTX-M-producing Enterobacteriaceae. A dose of 5 mg/kg targeting the low K. pneumoniae inoculum cured all the rats and averted an outbreak of clinical disease, all without any amplification of CTX-M-producing Enterobacteriaceae. These findings might have implications for the development of new antimicrobial treatment strategies that ensure a cure for bacterial infections while avoiding the amplification of resistance genes of human concern in the gut microbiota of food-producing animals.
Mots-clés : cefquinome klebsiella pneumoniae résistance antibiotique antibiotic resistance flore feces fecal flora
Type de document :
Article dans une revue
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2014, 58 (3), pp.1744-8. 〈10.1128/AAC.02135-13〉
Liste complète des métadonnées
https://hal-anses.archives-ouvertes.fr/hal-00978511
Contributeur : Emmanuelle Chiffoleau <>
Soumis le : lundi 14 avril 2014 - 12:09:51
Dernière modification le : mercredi 29 novembre 2017 - 09:49:07

Lien texte intégral

openaccess

Identifiants

Collections

ANSES | INRA

Citation

Maleck V Vasseur, Michel Laurentie, Jean-Guy Rolland, Agnès Perrin-Guyomard, Jérôme Henri, et al.. Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2014, 58 (3), pp.1744-8. 〈10.1128/AAC.02135-13〉. 〈hal-00978511〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

86

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD